Clinical Trials Browser

OTHER × Cyclophosphamide × Tumor-Agnostic × Clear all

NCT00420563 2026-03-16

PAL-ANGI

Phase 2 Completed

Neoplasms

NCT01374620 2026-03-16

PAL-ANGI2

Phase 1 Completed

Neoplasms

NCT02813135 2026-01-16

ESMART

Phase 1/2 Recruiting

Neoplasms

NCT06043713 2025-12-19

Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations

Phase 1 Recruiting

Neoplasm Metastasis

NCT01697527 2025-11-24

Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies

Phase 2 Active not recruiting

Neoplasms

NCT05631899 2025-11-24

CAR-DC Vaccine and ICIs in Local Advanced/Metastatic Solid Tumors

Phase 1 Active not recruiting

Neoplasm Metastasis

NCT02775292 2025-07-30

NYM

Phase 1 Completed

Neoplasm Metastasis

NCT01871441 2025-05-16

Haploidentical Donor Hematopoietic Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Phase 2 Terminated

4 enrolled 10 charts

Neoplasms

NCT05141474 2024-11-07

NEXTGENTIL-ACT

Phase EARLY_PHASE1 Recruiting

Carcinoma

NCT05601830 2024-11-06

Natural Killer(NK) Cell Therapy for AML Minimal Residual Disease

Phase 1 Terminated

Neoplasm, Residual

NCT03296137 2024-10-26

Adoptive Cell Therapy Across Cancer Diagnoses

Phase 1/2 Completed

25 enrolled 9 charts

Neoplasms

NCT06013111 2024-02-21

An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+ Locally Advanced and/or Metastatic Solid Tumors

Phase 1 Recruiting

Carcinoma

NCT00246103 2017-02-23

Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies

Phase 1 Completed

Neoplasms

NCT00165451 2011-07-07

A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer

Phase 2 Completed

Neoplasms